21 results
424B5
GLYC
GlycoMimetics Inc
28 Apr 22
Prospectus supplement for primary offering
5:01pm
the degree of market acceptance by physicians, patients, third-party payors and others in the medical community necessary for commercial success.
We face
10-Q
2014 Q1
GLYC
GlycoMimetics Inc
9 May 14
Quarterly report
12:00am
, if and when approved, whether alone or in collaboration with others;
acceptance of the drugs, if and when approved, by patients, the medical community … by physicians, patients, third-party payors and others in the medical community necessary for commercial success.
If any of our drug candidates receives
10-K
lbw5fay2arn6
31 Mar 14
Annual report
12:00am
S-1
s2h0y9o74uenaqr
4 Oct 13
IPO registration
12:00am
424B4
2d9d bn9vfrtj
10 Jan 14
Prospectus supplement with pricing info
12:00am
PRE 14A
1elrdwb3we4dt
22 Mar 24
Preliminary proxy
5:00pm
S-1
EX-10.1
rgkldzeh x9gm0e7itp
4 Oct 13
IPO registration
12:00am